Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare
27 August 2024 - 12:45PM
Business Wire
- PfizerForAll makes managing everyday health quicker and more
convenient for millions of Americans
- Platform is designed for patients with migraine, COVID-19 or
flu, and adults seeking vaccines for preventable diseases,
including COVID-19, flu, RSV and pneumococcal pneumonia
- End-to-end offering gives people an easier way to connect with
a qualified healthcare professional the same day, find and book
vaccines, receive tests and medications at home or via a preferred
pharmacy, and find savings and support if prescribed a Pfizer
medicine
- PfizerForAll works within the existing healthcare system and
through a growing network of partners to simplify access via
established channels and to close gaps in care
Pfizer Inc. (NYSE: PFE) today introduced PfizerForAll, a
user-friendly digital platform designed to make access to
healthcare and managing health and wellness more seamless for
people across the U.S. The new, end-to-end experience will support
the millions of Americans affected annually by common illnesses
like migraine, COVID-19 or flu, and those seeking to protect
themselves with adult vaccinations. By bringing together critical
resources and services into a single destination, PfizerForAll
helps individuals and their families cut down on the time and steps
needed to take important health actions like getting care, filling
prescriptions, and finding potential savings on Pfizer
medicines.
Pfizer is working within the existing U.S. healthcare system and
partnering with a growing network of healthcare organizations to
launch and develop PfizerForAll. Patients will be able to use
existing insurance and pharmacy programs and will also benefit from
new direct services from partners including UpScriptHealth, Alto
Pharmacy and Instacart.
“People often experience information overload and encounter
roadblocks when making decisions for themselves or their family in
our complex and often overwhelming U.S. healthcare system. This can
be extremely time-consuming and lead to indecision or inaction –
and as a result, poor health outcomes,” said Aamir Malik, Executive
Vice President, Chief U.S. Commercial Officer, Pfizer. “We are
pleased to offer PfizerForAll to help relieve this burden on
people, especially as we enter the fall season in the U.S., and
streamline the path for those seeking better health.”
PfizerForAll responds to an acute need in the U.S. healthcare
landscape. A recent poll by the American Academy of Physician
Associates found that 65% of Americans say coordinating and
managing healthcare is overwhelming and time-consuming, and 73% of
Americans feel that the healthcare system is failing to meet their
needs.1 Further, a majority of patients want more digital options
for managing their care.2
At launch, PfizerForAll offers:
- Access to same-day appointments with independent healthcare
professionals, either in-person or via telehealth. People
living with migraine or suffering from common respiratory symptoms
can connect to qualified healthcare professionals within minutes,
no matter where they are in the U.S., or find a provider in their
local area with availability.
- Home delivery of prescription medicines, over-the-counter
treatments and diagnostic tests. Patients can have prescription
medicines delivered either directly to their home or for pick up at
a preferred local pharmacy. People can also order over-the-counter
treatments and diagnostic tests for COVID-19 and flu.
- Appointment scheduling for adult COVID-19, flu, RSV
and pneumococcal pneumonia vaccinations. All adults over the
age of 18 can check their eligibility for COVID-19, flu, RSV and
pneumococcal vaccines, find vaccine availability in their local
area and book an appointment at a preferred retail pharmacy.
- Help paying for Pfizer medicines and access to patient
support services. PfizerForAll puts Pfizer’s savings and
support solutions in one place, making it easier for patients with
commercial insurance to find co-pay cards and for eligible patients
to access Pfizer’s affordability programs and patient support
services. Among other resources, patients can access information to
assist with efficiently navigating the insurance process for those
prescribed migraine and COVID-19 treatments, including a live
customer support option.
Pfizer will continue to expand and develop PfizerForAll to
improve the healthcare experience for people in the U.S., with the
potential to address a broader range of needs and conditions.
Visitors to PfizerForAll.com can register to receive regular
updates on new features, partners and services.
About Pfizer: Breakthroughs That Change Patients’
Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
175 years, we have worked to make a difference for all who rely on
us. We routinely post information that may be important to
investors on our website at www.Pfizer.com. In addition, to learn
more, please visit us on www.Pfizer.com and follow us on X at
@Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook
at Facebook.com/Pfizer.
Disclosure Notice
The information contained in this release is as of August 27,
2024. Pfizer assumes no obligation to update forward-looking
statements contained in this release as the result of new
information or future events or developments.
This release contains forward-looking information about Pfizer’s
launch of PfizerForAll, a digital platform designed to help
simplify access to healthcare, including its potential benefits and
anticipated offerings, that involves substantial risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied by such statements. Risks and
uncertainties include, among other things, uncertainties regarding
the impact of PfizerForAll on Pfizer’s business, operations and
financial condition and results; risks related to the ability to
realize the anticipated benefits of PfizerForAll, including the
possibility that the expected benefits will not be realized or will
not be realized within the expected time period; the uncertainties
inherent in business and financial planning, including, without
limitation, risks related to Pfizer’s business and prospects,
adverse developments in Pfizer’s markets, or adverse developments
in the U.S. or global capital markets, credit markets, regulatory
environment or economies generally; uncertainties regarding the
impact of COVID-19 on Pfizer’s business, operations and financial
results; and competitive developments.
A further description of risks and uncertainties can be found in
Pfizer’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2023 and in its subsequent reports on Form 10-Q,
including in the sections thereof captioned “Risk Factors” and
“Forward-Looking Information and Factors That May Affect Future
Results”, as well as in its subsequent reports on Form 8-K, all of
which are filed with the U.S. Securities and Exchange Commission
and available at www.sec.gov and www.pfizer.com.
1 The Harris Poll. The Patient Experience - Perspective on
Today’s Healthcare. N.d. Accessed on July 12, 2024.
https://www.aapa.org/research/patient-experience/ 2 Experian
Health. State of Patient Access 2023: The Digital Front Door. April
19, 2023. Accessed July 12, 2024.
https://www.experian.com/blogs/healthcare/state-of-patient-access-2023-the-digital-front-door/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240826802951/en/
Media Contact: PfizerMediaRelations@Pfizer.com +1 (212) 733-1226
Investor Contact: IR@Pfizer.com +1 (212) 733-4848
Pfizer (NYSE:PFE)
Historical Stock Chart
Von Sep 2024 bis Okt 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
Von Okt 2023 bis Okt 2024